Concepedia

Lars Grundemar

LG

37

Publications

1.6K

Citations

26

H-Index

1988

Active since

Affiliations

Lund University(Current)

Ferring Pharmaceuticals (Denmark)

Cornell University

Georgetown University

Karolinska University Hospital

Lars Grundemar is an author at Lund University specializing in medicine, physiology, and neuropharmacology.

Top concepts

Publications per year

1988–2020

37

Publications

37

Characterization of vascular neuropeptide Y receptors

Lars Grundemar, S. Jonas, N. A. Mörner et al. · British Journal of Pharmacology · 1992 · 121 citations · Full text

Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem.

Lars Grundemar, Claes Wahlestedt, D.J. Reis · Journal of Pharmacology and Experimental Therapeutics · 1991 · 111 citations

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

James A. Russell, Jean‐Louis Vincent, Anne Louise Kjølbye et al. · Critical Care · 2017 · 103 citations · Full text

Pitfalls using metalloporphyrins in carbon monoxide research

Lars Grundemar, Lars Ny · Trends in Pharmacological Sciences · 1997 · 97 citations

, , +1

Different pharmacokinetic and pharmacodynamic properties of recombinant follicle‐stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non‐human cell line

Håkan Olsson, Rikard Sandström, Lars Grundemar · The Journal of Clinical Pharmacology · 2014 · 88 citations

, , +21

Rows per page

1–5 of 37